XML 154 R163.htm IDEA: XBRL DOCUMENT v3.20.1
Parent Company only Condensed Financial Information - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:                      
Net Income $ 5,685 $ 11,277 $ 11,353 $ 12,146 $ 13,232 $ 12,375 $ 915 $ 8,809 $ 40,461 $ 35,331 $ 23,828
Adjustments to reconcile net income to net cash provided by operations:                      
Amortization of restricted stock award, net                 1,283 1,109 912
Net cash provided by operating activities                 50,343 48,572 41,358
Cash flows from financing activities:                      
Issuance of subordinated debt, net of issuance costs                     39,073
Proceeds from exercise of stock options                 1,626 2,667 1,368
Net cash provided by (used in) financing activities                 (28,780) (277,882) 246,052
Net increase (decrease) in cash and cash equivalents                 292,802 (151,654) 50,119
Cash and cash equivalents, beginning of period       164,568       316,222 164,568 316,222 266,103
Cash and cash equivalents, end of period 457,370       164,568       457,370 164,568 316,222
HCC (Parent)                      
Cash flows from operating activities:                      
Net Income                 40,461 35,331 23,828
Adjustments to reconcile net income to net cash provided by operations:                      
Amortization of restricted stock award, net                 1,283 1,109 912
Equity in undistributed net income of subsidiary bank                 (21,757) (22,161) (10,078)
Net change in other assets and liabilities                 12 (64) 224
Net cash provided by operating activities                 19,999 14,215 14,886
Cash flows from financing activities:                      
Equity investment in subsidiary bank                     (20,000)
Payment of cash dividends                 (22,723) (18,464) (15,238)
Issuance of subordinated debt, net of issuance costs                     39,073
Proceeds from exercise of stock options                 1,626 2,667 1,368
Net cash provided by (used in) financing activities                 (21,097) (15,797) 5,203
Net increase (decrease) in cash and cash equivalents                 (1,098) (1,582) 20,089
Cash and cash equivalents, beginning of period       $ 21,358       $ 22,940 21,358 22,940 2,851
Cash and cash equivalents, end of period $ 20,260       $ 21,358       $ 20,260 $ 21,358 $ 22,940